Bailard »

Cytek Biosciences shares owned by Bailard

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Bailard

Quarter filed Position value Share count Share price at filing
2025-09-30 $102k 29k 3.47
2024-12-31 $123k 19k 6.49

More positions owned by Bailard

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Eafe Etf (EFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Vanguard World Inf Tech Etf (VGT)
Ishares Tr Calif Mun Bd Etf (CMF)
Gilead Sciences (GILD)
Ishares Tr Ibonds 26 Trm Ts (IBTG)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Mortgage Backed (JMTG)

View all positions for Bailard

Top funds holding Cytek Biosciences

BlackRock
Vanguard Group
Hillhouse Capital Advisors
Brown Capital Management
State Street Corporation
Millennium Management
Dimensional Fund Advisors
Geode Capital Management
Wellington Management Company
Royce & Associates
Goldman Sachs Group
Morgan Stanley
Charles Schwab Investment Management
AQR Capital Management
Northern Trust

View all funds holding Cytek Biosciences